Risk of Adverse Outcomes in Asthma Patients following Total Shoulder Arthroplasty

sahap94@gmail.com

DOI: doi.org/10.70885/hmsj.2026.11.001

Abstract

Background: Asthma is a common condition, and as its incidence increases, the number of patients undergoing total shoulder arthroplasty (TSA) with this condition will also increase.Purpose: To investigate the relationship of asthma with adverse outcomes after TSA, allowing better risk stratification of patients who may be eligible for single-day surgery.Hypothesis: Asthma is an independent risk factor for increased postoperative adverse events, with greater asthma severity correlating with worse outcomes.Methods: Using a national claims database (2015 to 2021), patients aged 18 years and older who underwent primary anatomic or reverse TSA for osteoarthritis, with and without asthma, were identified using diagnosis and procedure codes. Asthma severity (mild intermittent, mild persistent, moderate, severe) was assigned from ICD-10 codes. Cohorts were matched 1:4 on age, sex, Charlson Comorbidity Index, obesity, smoking, and rheumatoid arthritis. Multivariate logistic regression compared 90-day adverse events and 5-year aseptic revision.Results: The matched cohort comprised 173,071 patients, 35,148 (20.3%) with asthma. Asthma was associated with higher odds of deep vein thrombosis (odds ratio [OR] = 1.23), atelectasis (OR = 1.23), and emergency department visits (OR = 1.1), and lower odds of respiratory failure (OR = 0.83). By severity, every group had higher odds of atelectasis, emergency department visits, all adverse events (OR = 1.18 to 1.44), and severe adverse events (OR = 1.19 to 1.31). Respiratory failure odds rose with severity (mild persistent OR = 1.28, moderate OR = 1.55, severe OR = 2.34). Severe asthma was also associated with pneumonia (OR = 2.10), sepsis (OR = 1.68), and readmission (OR = 1.38). Moderate and severe asthma had higher odds of minor adverse events. Aseptic revision at 5 years did not differ (OR = 1.05).Conclusion: Asthma, regardless of severity, was associated with higher odds of 90-day all-cause and severe adverse events, atelectasis, and emergency department visits after total shoulder arthroplasty, and respiratory failure odds increased with severity. Effect sizes were modest, and causality cannot be inferred. Orthopedic surgeons should consider asthma and its severity in preoperative counseling and perioperative planning.What this study adds: Asthma of any severity modestly raised early complication risk after TSA, with respiratory failure risk rising with severity but no difference in 5-year revision.How this study might affect research, practice or policy: Surgeons should assess asthma severity when counseling patients and selecting candidates for single-day TSA, and prospective studies should test whether preoperative optimization reduces risk.Study Design: Retrospective cohort studyLevel of Evidence: IIIKeywords: Arthroplasty; Joint; Orthopedics; Shoulder; Sport medicinehttps://doi.org/10.70885/hmsj.2026.11.001

References

  1. Flurin PH, Marczuk Y, Janout M, et al. Comparison of outcomes using anatomic and reverse total shoulder arthroplasty. Bull Hosp Jt Dis. 2013;71 Suppl 2:101–7.
  2. Carter MJ, Mikuls TR, Nayak S, et al. Impact of total shoulder arthroplasty on generic and shoulder-specific health-related quality-of-life measures: a systematic literature review and meta-analysis. J Bone Joint Surg Am. 2012;94:e127. doi:10.2106/jbjs.K.00204.
  3. Norris TR, Iannotti JP. Functional outcome after shoulder arthroplasty for primary osteoarthritis: a multicenter study. J Shoulder Elbow Surg. 2002;11:130–5. doi:10.1067/mse.2002.121146.
  4. Deshmukh AV, Koris M, Zurakowski D, et al. Total shoulder arthroplasty: long-term survivorship, functional outcome, and quality of life. J Shoulder Elbow Surg. 2005;14:471–9. doi:10.1016/j.jse.2005.02.009.
  5. Bixby EC, Boddapati V, Anderson MJJ, et al. Trends in total shoulder arthroplasty from 2005 to 2018: lower complications rates and shorter lengths of stay despite patients with more comorbidities. JSES Int. 2020;4:657–61. doi:10.1016/j.jseint.2020.04.024.
  6. Iannotti JP, Norris TR. Influence of preoperative factors on outcome of shoulder arthroplasty for glenohumeral osteoarthritis. J Bone Joint Surg Am. 2003;85:251–8. doi:10.2106/00004623-200302000-00011.
  7. Shengyuan T, Zihang X, Changbing W, et al. The influence of obesity on the complications and outcomes of shoulder arthroplasty: a systematic review and meta-analysis. Acta Orthop Traumatol Turc. 2023;57:154–60. doi:10.5152/j.aott.2023.20300.
  8. Cogan CJ, Flores SE, Freshman RD, et al. Effect of obesity on short- and long-term complications of shoulder arthroplasty. J Shoulder Elbow Surg. 2023;32:253–9. doi:10.1016/j.jse.2022.07.028.
  9. Ling K, Smolev E, Tantone RP, et al. Smoking is an independent risk factor for complications in outpatient total shoulder arthroplasty. JSES Int. 2023;7:2461–6. doi:10.1016/j.jseint.2023.07.009.
  10. Duey AH, White CA, Levy KH, et al. Diabetes increases risk for readmission and infection after shoulder arthroplasty: A national readmissions study of 113,713 patients. J Orthop. 2023;38:25–9. doi:10.1016/j.jor.2023.03.003.
  11. Ahmed AF, Hantouly A, Toubasi A, et al. The safety of outpatient total shoulder arthroplasty: a systematic review and meta-analysis. Int Orthop. 2021;45:697–710. doi:10.1007/s00264-021-04940-7.
  12. Swed S, Sawaf B, Al-Obeidat F, et al. Asthma prevalence among United States population insights from NHANES data analysis. Sci Rep. 2024;14:8059. doi:10.1038/s41598-024-58429-5.
  13. Numata T, Nakayama K, Fujii S, et al. Risk factors of postoperative pulmonary complications in patients with asthma and COPD. BMC Pulm Med. 2018;18:4. doi:10.1186/s12890-017-0570-8.
  14. Smith-Voudouris J, Rubin LE, Grauer JN. Risk of adverse events following total knee arthroplasty in asthma patients. J Am Acad Orthop Surg. 2024;32:543–9. doi:10.5435/jaaos-d-23-01142.
  15. Grau L, Orozco FR, Duque AF, et al. A simple protocol to stratify pulmonary risk reduces complications after total joint arthroplasty. J Arthroplasty. 2019;34:1233–9. doi:10.1016/j.arth.2019.01.048.
  16. Yang IV, Lozupone CA, Schwartz DA. The environment, epigenome, and asthma. J Allergy Clin Immunol. 2017;140:14–23. doi:10.1016/j.jaci.2017.05.011.
  17. Meirlaen L, Levy EI, Vandenplas Y. Prevention and management with pro-, pre and synbiotics in children with asthma and allergic rhinitis: a narrative review. Nutrients. 2021;13. doi:10.3390/nu13030934.
  18. Na SS, Kim DH, Choi BC, et al. Incidence, characteristics, and risk factors of venous thromboembolism in shoulder arthroplasty: a systematic review. Int Orthop. 2022;46:2081–8. doi:10.1007/s00264-022-05496-w.
  19. Saleh HE, Pennings AL, ElMaraghy AW. Venous thromboembolism after shoulder arthroplasty: a systematic review. J Shoulder Elbow Surg. 2013;22:1440–8. doi:10.1016/j.jse.2013.05.013.
  20. Gupta AK, Chalmers PN, Rahman Z, et al. Reverse total shoulder arthroplasty in patients of varying body mass index. J Shoulder Elbow Surg. 2014;23:35–42. doi:10.1016/j.jse.2013.07.043.
  21. Smith CAR, Lo Y, Stallone S, et al. Predictors of return to emergency department and readmission following primary elective total shoulder arthroplasty. Arch Bone Jt Surg. 2024;12:477–86. doi:10.22038/ABJS.2024.77508.3581.
  22. Lin CS, Chang CC, Yeh CC, et al. Postoperative adverse outcomes in patients with asthma: a nationwide population-based cohort study. Medicine (Baltimore). 2016;95:e2548. doi:10.1097/md.0000000000002548.
  23. Bruin MM, Deijkers RLM, Bus MPA, et al. Inhaled corticosteroids, vitamin K antagonists and amlodipine were associated with an increased risk of acute periprosthetic joint infection in patients with total hip arthroplasty: a retrospective case-cohort study. J Clin Med. 2022;11. doi:10.3390/jcm11071842.
  24. Ravi V, Murphy RJ, Moverley R, et al. Outcome and complications following revision shoulder arthroplasty: a systematic review and meta-analysis. Bone Jt Open. 2021;2:618–30. doi:10.1302/2633-1462.28.BJO-2021-0092.R1.
  25. Euser AM, Zoccali C, Jager KJ, et al. Cohort studies: prospective versus retrospective. Nephron Clin Pract. 2009;113:c214–7. doi:10.1159/000235241.

Full text PDF